New York, USA, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Global Neuroendoscopy Market to Exhibit Growth at a CAGR of ~5% by 2030| DelveInsight
The surge in neuroendoscopy demand is chiefly fueled by the increasing occurrence of neurological conditions like brain tumors. Furthermore, the escalating need for less invasive treatments and the array of benefits linked with neuroendoscopic procedures are significant factors propelling the expansion of the neuroendoscopy market.
DelveInsight’s Neuroendoscopy Market Insights report provides the current and forecast market analysis, individual leading neuroendoscopy companies’ market shares, challenges, neuroendoscopy market drivers, barriers, trends, and key market neuroendoscopy companies in the market.
Key Takeaways from the Neuroendoscopy Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global neuroendoscopy market during the forecast period.
- In the product segment of the neuroendoscopy market, the flexible neuroendoscopy category had a significant revenue share in the neuroendoscopy market in 2023. This can be attributed to the various advantages provided by flexible neuroendoscopy.
- Notable neuroendoscopy companies such as Adeor Medical AG, Machida Endoscope Co. Ltd, B. Braun SE, Schindler Endoskopie Technologie GmbH, Clarus Medical LLC, KARL STORZ, Locamed Ltd., Ackermann Instrumente GmbH, Tonglu Wanhe Medical Instruments Co., Ltd., Renishaw plc, Cliniva Healthcare, Advin Healthcare, Aesculap Inc., ClearMind Biomedical, and several others, are currently operating in the neuroendoscopy market.
- In August 2021, ClearPoint Neuro Inc. entered into a strategic and commercial partnership with German-based surgical equipment leader Adeor Medical AG.
- In January 2021, the FDA granted 510k clearance to ClearMind Biomedical's new neuroendoscope, the Axonpen System.
To read more about the latest highlights related to the neuroendoscopy market, get a snapshot of the key highlights entailed in the Global Neuroendoscopy Market Report
Neuroendoscopy Overview
Neuroendoscopy stands at the frontier of modern neurosurgery, offering minimally invasive solutions to a spectrum of neurological conditions. Through the strategic use of endoscopes, equipped with high-resolution cameras and specialized instruments, neurosurgeons gain access to the intricate structures of the brain and spine with unparalleled precision. This innovative technique has revolutionized the management of various disorders, including hydrocephalus, tumors, cysts, and certain vascular malformations. By navigating through natural pathways or creating tiny incisions, neuroendoscopy reduces trauma to surrounding tissues, resulting in shorter hospital stays, faster recovery times, and diminished risks compared to traditional open surgeries.
Moreover, the versatility of neuroendoscopy extends beyond therapeutic interventions, offering diagnostic benefits as well. With its ability to visualize anatomical structures in real-time, neuroendoscopic procedures aid in the accurate diagnosis of conditions such as intraventricular hemorrhage or certain types of brain tumors. Additionally, advancements in technology continue to refine neuroendoscopic techniques, enabling surgeons to tackle increasingly complex cases with greater efficacy. As the field of neuroendoscopy continues to evolve, its role in neurosurgical practice is poised to expand, offering patients renewed hope and neurosurgeons powerful tools to navigate the intricate landscape of the human brain.
Neuroendoscopy Market Insights
In 2023, North America led the neuroendoscopy market, primarily due to its large population of patients grappling with diverse neurological conditions like brain tumors. This dominance is underpinned by the region's advanced healthcare infrastructure, continuous technological innovations, and a robust market for product development and launches.
For instance, in the United States alone, around 24,810 cases of brain and spinal cord tumors were diagnosed in 2023, with 5,230 cases reported among children under 20 years old. This escalating prevalence of neurological disorders necessitates effective treatment and management, thus driving the demand for neuroendoscopy procedures and fostering market growth in the region.
Moreover, the neuroendoscopy market in North America benefits from key product launches and approvals. A notable example is ClearMind Biomedical's Axonpen System, which received 510k clearance from the US FDA in January 2021, contributing to the positive trajectory of the neuroendoscopy market in the region.
To know more about why North America is leading the market growth in the neuroendoscopy market, get a snapshot of the Neuroendoscopy Market Outlook
Neuroendoscopy Market Dynamics
The neuroendoscopy market has been witnessing dynamic growth owing to several factors, including advancements in technology, increasing prevalence of neurological disorders, and rising demand for minimally invasive surgical procedures. Neuroendoscopy involves the use of small, flexible instruments equipped with cameras to access and treat conditions within the brain and spinal cord. This approach offers numerous benefits, such as reduced surgical trauma, shorter recovery times, and improved patient outcomes, which have contributed to its growing adoption.
One of the key drivers of the neuroendoscopy market is the continuous innovation in endoscopic techniques and equipment. Manufacturers are constantly developing new tools and technologies to enhance the precision, efficiency, and safety of neuroendoscopic procedures. This includes improvements in imaging capabilities, instrument design, and navigation systems, allowing surgeons to perform complex interventions with greater accuracy and control.
Moreover, the increasing incidence of neurological disorders such as hydrocephalus, brain tumors, and intracranial cysts is fueling the demand for neuroendoscopic procedures. As the global population ages and the prevalence of conditions like Alzheimer's disease and Parkinson's disease rises, there is a growing need for effective treatment options that minimize complications and improve patient quality of life. Neuroendoscopy offers a less invasive alternative to traditional open surgeries, making it particularly appealing for elderly or frail patients.
Furthermore, healthcare providers are increasingly recognizing the economic benefits of neuroendoscopy. Minimally invasive procedures typically result in shorter hospital stays, reduced post-operative complications, and lower overall healthcare costs compared to traditional surgeries. This has led to greater adoption of neuroendoscopic techniques by hospitals and surgical centers, driving market growth.
However, despite the promising outlook, the neuroendoscopy market also faces challenges such as high initial costs associated with equipment acquisition and training, as well as the need for specialized skills among surgeons. Additionally, reimbursement policies and regulatory requirements vary across regions, impacting the accessibility and adoption of neuroendoscopic procedures in different healthcare systems. Overall, while the neuroendoscopy market continues to evolve, addressing these challenges will be crucial for sustained growth and widespread adoption of this innovative approach to neurological surgery.
Get a sneak peek at the neuroendoscopy market dynamics @ Neuroendoscopy Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2021–2030 |
| Neuroendoscopy Market CAGR | ~5% |
| Key Neuroendoscopy Companies | Adeor Medical AG, Machida Endoscope Co. Ltd, B. Braun SE, Schindler Endoskopie Technologie GmbH, Clarus Medical LLC, KARL STORZ, Locamed Ltd., Ackermann Instrumente GmbH, Tonglu Wanhe Medical Instruments Co., Ltd., Renishaw plc, Cliniva Healthcare, Advin Healthcare, Aesculap Inc., ClearMind Biomedical, among others |
Neuroendoscopy Market Assessment
- Neuroendoscopy Market Segmentation
- Neuroendoscopy Market Segmentation By Product: Rigid Neuroendoscopes and Flexible Neuroendoscopes
- Neuroendoscopy Market Segmentation By Application: Transnasal Neuroendoscopy, Intraventricular Neuroendoscopy, and Transcranial Neuroendoscopy
- Neuroendoscopy Market Segmentation By Usability: Reusable and Disposable
- Neuroendoscopy Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, and Others
- Neuroendoscopy Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the neuroendoscopy market are set to emerge as the trendsetter explore @ Neuroendoscopy Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | Neuroendoscopy Market Layout |
| 7 | Global Company Share Analysis – Key 3-5 Companies |
| 8 | Neuroendoscopy Market Company and Product Profiles |
| 9 | Project Approach |
| 10 | About DelveInsight |
Interested in knowing the neuroendoscopy market by 2030? Click to get a snapshot of the Neuroendoscopy Market Trends
Related Reports
Parkinson’s Disease Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Parkinson’s disease companies, including Cerevel Therapeutics, Pfizer, Pharma Two B, AbbVie, Biogen, Denali Therapeutics, Annovis Bio, Amneal Pharmaceuticals, BioVie, Cerevance, Clene Nanomedicine, Intra-Cellular Therapies, Hoffmann-La Roche, Prothena Corp, among others.
Alzheimer's Disease Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Alzheimer’s disease companies including Biogen, AZTherapies, Cerecin, Neurotrope, Synaptogenix, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex Life Sciences, Athira Pharma, Time Therapeutics, Denali Therapeutics Inc., Alector Inc., Lexeo Therapeutics, TrueBinding, Inc., Vaccinex Inc., Annovis Bio Inc., Eisai Inc., Hoffmann-La Roche, Ionis Pharmaceuticals, Inc., Otsuka Pharmaceutical Co., Ltd., Cognition Therapeutics, Merck Sharp & Dohme LLC, ImmunoBrain Checkpoint, AbbVie, AriBio Co., Ltd., Oryzon Genomics S.A., Eli Lilly and Company, Neurokine Therapeutics, Excelsior, Seelos Therapeutics, Inc., Janssen Research & Development, LLC, Shanghai Hengrui Pharmaceutical Co., Ltd., reMYND, Alzinova AB, VTBIO Co. LTD, BioVie Inc., Prothena Corporation plc, Coya Therapeutics, Inc., among others.
Psychosis in Parkinson’s and Alzheimer’s Disease Market
Psychosis in Parkinson’s and Alzheimer’s Disease Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key psychosis in Parkinson’s and Alzheimer’s disease companies, including Sunovion Pharmaceuticals, Karuna Therapeutics, Vanda Pharmaceuticals, Suven Life Sciences, Enterin, Intra-Cellular Therapies, Merck Sharp & Dohme, among others.
Traumatic Brain Injury Pipeline
Traumatic Brain Injury Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key traumatic brain injury companies, including Life Molecular Imaging SA, Hope Biosciences, Merz Pharmaceuticals GmbH, Vasopharm GmbH, Pinteon Therapeutics, among others.
Traumatic Brain Injury Assessment Devices Market
Traumatic Brain Injury Assessment Devices Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key macular edema companies including BrainScope Company Inc, NOVASIGNAL CORPORATION, Compumedics Limited, Integra LifeSciences Corporation, Natus Medical Incorporated, InfraScan Inc, Dr. Langer Medical GmbH, RAUMEDIC AG, SyncThink Inc, Imeka, General Electric Company, pro2cool Tectrum, NanoDx, NIHON KOHDEN CORPORATION, Elekta, Advanced Brain Monitoring Inc, Boston Scientific Corporation, ESAOTE SPA, Koninklijke Philips N.V, Vivonics Inc., among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
